These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 183943)

  • 1. [Treatment of essential hypertension with propranolol (author's transl)].
    Klumpp F; Braun B; Klaus D; Lemke R; Zehner J
    Dtsch Med Wochenschr; 1976 Oct; 101(41):1482-8. PubMed ID: 183943
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Plasma renin activity and plasma aldosterone in essential hypertension: effect of age and diastolic blood pressure].
    Vetter H; Alasso I; Appenheimer M; Weiand H; Stelkens H; Lucas R; Glänzer K; Witassek F; Stumpe KO; Trübestein G; Krück F
    Schweiz Med Wochenschr; 1976 Dec; 106(49):1729-32. PubMed ID: 1013695
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Propranolol, renin and hypertension: a review.
    Laragh JH; Bühler FR
    Postgrad Med J; 1976; 52 Suppl 4(604):109-15. PubMed ID: 787950
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Sodium outflow rate through lymphocyte cell membranes, serum levels of sodium, potassium, aldosterone, total catecholamines, 6-keto- PGF2alpha and plasma renin activity in patients with primary arterial hypertension treated with captopril].
    Mazurek W; Halawa B; Borejko-Słopecka G
    Pol Tyg Lek; 1992 Jul 6-13; 47(27-28):588-93. PubMed ID: 1488334
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Metoprolol in high renin hypertension. A comparison with propranolol.
    Lameyer LD; Hesse CJ
    Ann Clin Res; 1981; 13 Suppl 30():16-22. PubMed ID: 7027889
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The hypotensive effect of propranolol: pathophysiological and clinical approach (author's transl)].
    Pessina AC; Corgnati A; Palù CD
    G Ital Cardiol; 1976; 6(2):290-9. PubMed ID: 1010180
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Effect of chronic beta-adrenergic blockade on blood pressure and release of renin, aldosterone and cortisol in essential hypertension (author's transl)].
    Stumpe KO; Vetter H; Hessenbruch V; Düsing R; Kolloch R; Krück F
    Klin Wochenschr; 1975 Oct; 53(19):907-11. PubMed ID: 241876
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Captopril in the treatment of essential hypertension (author's transl)].
    Lederle RM; Klaus D; Braun B
    Dtsch Med Wochenschr; 1980 Sep; 105(38):1307-12. PubMed ID: 6257467
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Beta-adrenergic blockade in essential hypertension. Effects of propranolol on hemodynamic parameters and plasma renin activity.
    Hansson L
    Acta Med Scand Suppl; 1973; 550():1-40. PubMed ID: 4201751
    [No Abstract]   [Full Text] [Related]  

  • 10. Comparison of chlorthalidone and spironolactone in low--renin essential hypertension.
    Kreeft JH; Larochelle P; Ogilvie RI
    Can Med Assoc J; 1983 Jan; 128(1):31-4. PubMed ID: 6336600
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Propranolol-hydralazine combination in essential hypertension.
    Stevens JD; Binstok G; Mullane JF; Woods JW; Pittman AW; del Greco F; Huang C; Morledge JH
    Clin Ther; 1983; 5(5):525-39. PubMed ID: 6352036
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Long-term minoxidil therapy: renin, aldosterone, noradrenaline and the need for beta blockers].
    Jaeger P; Brunner HR; Turini GA; Jéquier E; Ferguson RK; Gavras H
    Schweiz Med Wochenschr; 1978 Nov; 108(44):1707-9. PubMed ID: 715407
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of propranolol on cyclic AMP excretion and plasma renin activity in labile essentrial hypertension.
    Hamet P; Kuchel O; Cuche JL; Boucher R; Genest J
    Can Med Assoc J; 1973 Dec; 109(11):1099-103. PubMed ID: 4357222
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Metoprolol and propranolol in the treatment of essential hypertension - a long-term comparative study.
    Sjöberg KH
    Ann Clin Res; 1981; 13 Suppl 30():23-9. PubMed ID: 7027890
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Spironolactone and thiabutazide in the treatment of essential hypertension (author's transl)].
    Klump F; Braun B; Klaus D; Lemke R; Zehner J; Zöfel P
    Dtsch Med Wochenschr; 1975 Mar; 100(12):577-84. PubMed ID: 1168122
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The relative roles of sodium and renin in the hypertension of renal disease. An assessment based on the response to frusemide and propranolol.
    Wilkinson R; Sellars L; Pickering M; Robson V; Kerr DN
    Clin Nephrol; 1981 Dec; 16(6):307-13. PubMed ID: 7032775
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Propranolol-hydrochlorothiazide combination in essential hypertension.
    Stevens JD; Mullane JF
    Clin Ther; 1982; 4(6):497-509. PubMed ID: 7046937
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Plasma renin activity in essential hypertension: different short- und long-term effects of diuretics (author's transl)].
    Esch I; Placheta P; Gaul G
    Wien Klin Wochenschr; 1976 Jun; 88(13):415-8. PubMed ID: 824860
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effects of piretanide on catecholamine metabolism, plasma renin activity and serum aldosterone: a double-blind pilot comparison against hydrochlorothiazide in patients with essential hypertension.
    Verho M; Kirsten R; Bückert C
    Pharmatherapeutica; 1984; 3(9):595-606. PubMed ID: 6374680
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Treatment of essential hypertension with a combination of propranolol, spironolactone-thiabutazide and dihydralazine (author's transl)].
    Ebel H; Lübke H; Klaus D; Zehner J; Witzgall H
    Dtsch Med Wochenschr; 1978 Oct; 103(42):1650-5. PubMed ID: 699788
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.